Tag: biotechnology
-
Spin-Off Creates Enzyme to Prevent Celiac Disease
A spin-off enterprise from University of Washington is developing a synthetic enzyme that prevents dietary gluten from triggering symptoms of celiac disease.
-
Cell Biotech Gains Organoid Technology
A Canadian biotechnology enterprise is licensing a technology that generates organoids, three-dimensional clusters of cells from stem cells that can form into gastrointestinal organs.
-
Trial to Explore Microbiome Therapy for Hypertension
A clinical trial is set to begin that tests live bacteria as a treatment for hypertension, or high blood pressure, a condition affecting 1 in 3 adults in the U.S.
-
Peptide-Infused Gel Shown to Heal Chronic Wounds
A tissue engineering group developed a gel material infused with a synthetic peptide that in lab cultures and animals healed chronic diabetic wounds faster than a current commercial treatment.
-
Patent Awarded for Whooping Cough Antibodies
An experimental treatment for pertussis, also known as whooping cough, using engineered humanized antibodies received a patent in the U.S.
-
Stem Cell Therapy Company Formed, Staked to $225M
A pharmaceutical company and health care venture investor are forming BlueRock Therapeutics, a biotechnology enterprise to design regenerative medicine treatments with stem cells.
-
Engineered T-Cells Tested on Metastatic Cancer
An individual with lung cancer tumors that spread from the colon had the tumors reduced in size after a single treatment of modified cancer-killing immune system cells.
-
Synthetic Insulin-Producing Cells Designed, Tested
Synthetic beta cells, like natural cells in the pancreas, were shown in tests with lab mice to sense glucose levels in the blood and produce insulin.
-
Start-Up Reprogramming Stem Cells to Treat Heart Failure
A new enterprise, spun-off from the Gladstone Institutes in San Francisco, plans to regenerate heart muscle from other cells to treat heart failure.
-
Ostrich Antibodies to Fight Resistant Infections
A biotechnology company developing antibodies grown in ostrich eggs is partnering with a Boston hospital to test a new treatment for Clostridium difficile, or C. difficile, a stubborn infection, increasingly resistant to antibiotics, and often contracted in hospitals.